Startup launches with $86M to solve drug delivery problems with AI

METiS Therapeutics, based in Cambridge and China, is using machine learning and quantum simulations to develop small-molecule and RNA drugs for orphan diseases, central nervous system disorders and autoimmune diseases.

Source: bizjournals.com Health Care:Physician Practices headlines - December 7, 2021 Category: American Health Authors: Rowan Walrath Source Type: news